Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Comparison of Psychological and Pharmacological Treatments for Pain due to TMD
This study is currently recruiting patients.
Sponsored by: | National Institute of Dental and Craniofacial Research (NIDCR) |
---|---|
Information provided by: | National Institute of Dental and Craniofacial Research (NIDCR) |
Purpose
The purpose of this study is to determine whether the combination of cognitive-behavioral treatment and nortriptyline are more effective than each treatment alone in reducing the pain and disability associated with TMD.
Condition | Treatment or Intervention | Phase |
---|---|---|
Temporomandibular Joint Disorders |
Drug: nortriptyline Behavior: cognitive-behavioral treatment |
Phase II |
MedlinePlus related topics: Temporomandibular Joint Dysfunction
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Factorial Assignment, Efficacy Study
Official Title: Pain Management in Temporomandibular Joint Disorders
Expected Total Enrollment: 214
Study start: November 2002;
Study completion: September 2006
This is a randomized, controlled trial evaluating pharmacological (nortriptyline vs. active placebo - benztropine) and psychological (cognitive-behavioral therapy vs. disease education) treatments for pain and disability due to temporomandibular joint disorder (TMD). Patients 18 to 65 years old meeting RDC criteria for TMD and other eligibility criteria complete a 3-week baseline monitoring phase prior to randomization. Active treatment consists of weekly visits for 8 week, then maintenance treatment for 6 months. Outcome measures include pain, physical and psychosocial function and are assessed at post-treatment, 3-months, and 6-months
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion:
Exclusion:
Location and Contact Information
More Information
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |